08/30/06

References

1. APHA. Monograph 2 - Medication Therapy Management Services and Chronic Care Improvement Programs. In: Understanding Medicare Reform - What Pharmacists Need to Know. Washington, DC, 2004, p. 24.

2. Ashby DM and Manasse HR. Creating a unique vision for the profession. American Journal of Health-System Pharmacy 61: 1825-1832, 2004.

3. Baradell J and Hanrahan N. CPT coding and Medicare reimbursement issues. Clin Nurse Spec 14: 299-303, 2000.

4. Benrimoj SI, Peacocke G, Whitehead P, Kopecny E, Emerson L, and et al. Cognitive pharmaceutical services in emerging health care systems. J Soc Adm Pharm 20: 2-12, 2003.

5. Brown JB, Nichols GA, Glauber HS, Bakst AW, Schaeffer M, and Kelleher CC. Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus. American Journal of Health-System Pharmacy 58: 151-157, 2001.

6. Cantwell KM. Current issues affecting pharmacists and pharmacy personnel: Provider recognition, collaborative practice, and technician roles. ASHP Summer Meeting 60: PI-8, 2003.

7. Carmichael JM, Alvarez A, Chaput R, DiMaggio J, Magallon H, and Mambourg S. Establishment and outcomes of a model primary care pharmacy service system. American Journal of Health-System Pharmacy 61: 472-482, 2004.

8. Chrischilles EA, Helling DK, and Rowland CR. Clinical pharmacy services in family practice - cost-benefit analysis. II. Referrals, appointment compliance, and costs. Drug Intell Clin Pharm 18: 436-441., 1984.

9. DC S. Consumers' willingness to pay for pharmacy services that reduce risk of medication-related problems. J Am Pharm Assoc (Wash) 40: 818-827., 2000.

10. Dent LA, Stratton TP, and Cochran GA. Establishing an on-site pharmacy in a community health center to help indigent patients access medications and to improve care. J Am Pharm Assoc (Wash) 42: 497-507., 2002.

11. Donato R, March G, Moss J, and Gilbert A. Cost implications of the delivery of pharmaceutical care services through Australian community pharmacies. Int J Pharm Pract 9: 23-30, 2001.

12. Eisenberg JM. Clinical Economics - a Guide to the Economic-Analysis of Clinical Practices. Jama-Journal of the American Medical Association 262: 2879-2886, 1989.

13. Etemad LRPMS and Hay JWP. Cost-Effectiveness Analysis of Pharmaceutical Care in a Medicare Drug Benefit Program. Value in Health 6: 425-435, 2003.

14. Galbreath AD, Krasuski RA, Smith B, Stajduhar KC, Kwan MD, Ellis R, and Freeman GL. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 110: 3518-3526, 2004.

15. Gillespie JL and Rossiter LF. Medicaid Disease Management Programs: Findings from Three Leading US State Programs. [Article]. Disease Management & Health Outcomes 11: 345-361, 2003.

16. Hunsley J. Cost-Effectiveness and Medical Cost-Offset Considerations in Psychological Service Provision. Canadian Psychology 44: 61-73, 2003.

17. Johnson SC. Reimbursement for cognitive services - Case study in an anticoagulation clinic. ASHP Midyear Clinical Meeting 37: PI-88, 2002.

18. Kelly B. Seeking more payment for professional services - with the rewards come the obligations. Australian Journal of Pharmacy 85: 240-241, 2004.

19. Knapp KK, Katzman H, Hambright JS, and Albrant DH. Community pharmacist interventions in a capitated pharmacy benefit contract. American Journal of Health-System Pharmacy 55: 1141-1145, 1998.

20. Kosty T and Dietz D. Time to start documenting medication therapy management. Computertalk for the Pharmacist 24: 43-45, 2004.

21. Kuo GM, Buckley TE, Fitzsimmons DS, and Steinbauer JR. Collaborative drug therapy management services and reimbursement in a family medicine clinic. American Journal of Health-System Pharmacy 61: 343-354, 2004.

22. Kuperman GJMDP and Gibson RFMDP. Computer Physician Order Entry - Benefits, Costs, and Issues. Annals of Internal Medicine 139: 31-39, 2003.

23. Ly AN, Catania HF, Locke C, and Carlton PA. Development and implementation of a pharmacist managed medication disease clinic in a medical plaza. ASHP Midyear Clinical Meeting 37: MCS-47, 2002.

24. Marquess JG, Wickman JM, and Marshall LL. Design, development and implementation of a pharmaceutical care based pharmacy practice lab focusing on disease state management. AACP Annual Meeting 99: 81, 1998.

25. Melzer SM, Richards GE, and Covington ML. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale. Pediatric Diabetes 5: 133-142, 2004.

26. Meyer BM. A first step... toward full Medicare recognition of pharmacists as providers. American Journal of Health-System Pharmacy 61: 991, 2004.

27. Meyer BM and Cantwell KM. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003: implications for health-system pharmacy. American Journal of Health-System Pharmacy 61: 1042-1051, 2004.

28. Musich SA, Schultz AB, Burton WN, and Edington DW. Overview of Disease Management Approaches: Implications for Corporate-Sponsored Programs. [Review]. Disease Management & Health Outcomes 12: 299-326, 2004.

29. Nichols-English GJ, Provost M, Koompalum D, Chen H, and Athar M. Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs: New Roles in Primary and Collaborative Care. Disease Management & Health Outcomes 10: 783-803, 2002.

30. Nnadi M, Fields C, and Anderson C. Evaluation of pharmacotherapy outcome and cost savings of a pharmacy managed anticoagulation service. ASHP Midyear Clinical Meeting 32: P-328R, 1997.

31. Oberst RL. Clinical and financial justification of pharmacy services for thoracic organ transplant and mechanical heart programs. ASHP Midyear Clinical Meeting ASHP Midyear Clinical Meeting: P-564(D), 2003.

32. Patry RA, Snella KA, Hartman TJ, Lenz RJ, McCall KL, and Speasmaker HA. Development of a model to manage credentialling, privileging, reimbursement, and compliance in the ambulatory setting. ASHP Midyear Clinical Meeting 34: P-1D, 1999.

33. Piecoro LT, Potoski M, Talbert JC, and Doherty DE. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 36: 357-371, 2001.

34. Poirier S, Buffington DE, and Memoli GA. Billing third party payers for pharmaceutical care services. J Am Pharm Assoc (Wash) 39: 50-64; quiz 101-102, 1999.

35. Poole VH, Moran DW, and Webb CE. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001. Pharmacotherapy 23: 955-965, 2003.

36. Reddan JG, Sheehan AH, Eskew J, and Elmes G. Integration of a medication management infrastructure in a large, multihospital system. American Journal of Health-System Pharmacy 61: 2557-2561, 2004.

37. Rich DS. More questions and answers about the 2004 medication management standards. Hosp Pharm 39: 375-378,380,388, 2004.

38. Rich DS. New JCAHO medication management standards for 2004. American Journal of Health-System Pharmacy 61: 1349-1358, 2004.

39. Rohling ML, Binder LM, and Langhinrichsen-Rohling J. Money Matters - A Meta-Analytic Review of the Association Between Financial Compensation and the Experience and Treatment of Chronic Pain. Health Psychology 14: 537-547, 1995.

40. Scott M, Fritsch M, Powell L, and Durkee M. Collaborative drug therapy management. Pharmacy Times 67: 51-64, 2001.

41. Segarra-Newnham MPB and Soisson KTPB. Provision of Pharmaceutical Care Through Comprehensive Pharmacotherapy Clinics. Hosp Pharm 32: 845-850, 1997.

42. Spurgeon DG, Noble S, Byrd J, King D, Dancer T, Vinson M, Horton N, and Stevens B. New horizons - disease state management and reimbursement through collaborative practice agreements. ASHP Midyear Clinical Meeting 34: CRED-2, 1999.

43. Traynor K. Legislation calls for Medicare coverage of outpatient drugs, pharmacists' services. American Journal of Health-System Pharmacy 59: 494, 2002.

44. Traynor K. Proposed rule discusses Medicare medication management services. American Journal of Health-System Pharmacy 61: 1875-1876, 2004.

45. Weinstein MC and Stason WB. Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesFoundations of Cost-Effectiveness Analysis for .pdfHealth and Medical Practices. New England Journal of Medicine: 716-721, 1977.

46. Williams A. Cost-effectiveness analysis - is it ethical. J Med Ethics 18: 7-11, 1992.

47. Young D. Imperfect Medicare law has positive implications for pharmacists. American Journal of Health-System Pharmacy 61: 126, 128, 2004.